Yatich, Bett; McLigeyo, Angela
(BMC Cancer, 2022-02)
Background: Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics ...